Barnett & Company’s Hologic HOLX Stock Holding History

Barnett & Company’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-193	Closed	-$10K	–	393
2019 Q4	$10K	Buy	193 +182	+1,655%	+$9.06K	0.01%	319
2019 Q3	$1K	Buy	+11	New	+$541	﹤0.01%	374

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Barnett & Company's HOLX Position: Q1 2020 in Review

Barnett & Company sold out of Hologic (HOLX) in Q1 2020, closing a stake of 193 shares — an estimated $10K sold.

Barnett & Company first reported a position in HOLX in Q3 2019 and held it in 2 quarters. The position peaked at $10K in Q4 2019. 485 funds tracked by Wall St. Rank hold HOLX as of Q1 2020.

Barnett & Company reported no remaining Hologic position as of Q1 2020 after selling out during the quarter.
Barnett & Company sold 193 Hologic shares in Q1 2020, an estimated $10K.
Barnett & Company first reported a position in Hologic in Q3 2019 and held it in 2 quarters.
Barnett & Company's Hologic position peaked at $10K in Q4 2019.
485 funds tracked by Wall St. Rank held Hologic as of Q1 2020.

Based on Barnett & Company's 13F filing for Q1 2020, filed 23 Apr 2020.